Comments on the Eslicarbazepine Acetate Section of the Article 'Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications'
The recent review of Matthew D. Krasowski on 'Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications' is a useful foundation of comparative interpretations on our current knowledge about therapeutic drug monitoring. Within the review, the statement that therapeutic drug monitor...
Saved in:
Main Authors: | Patricio Soares- (Author), Ahmet H. Öztiryaki (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
by: Matthew D. Krasowski
Published: (2010) -
Social cognition and prefrontal cognitive function in patients with epilepsy treated with eslicarbazepine acetate
by: Laura Abraira, et al.
Published: (2017) -
Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
by: Martyna Stefaniak, et al.
Published: (2022) -
Inhibitory Effect of Eslicarbazepine Acetate and S-Licarbazepine on Nav1.5 Channels
by: Theresa K. Leslie, et al.
Published: (2020) -
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
by: Sunkaraneni S, et al.
Published: (2017)